Population pharmacokinetics of rivaroxaban after transjugular intrahepatic portosystemic shunt. [PDF]
Jia M +12 more
europepmc +1 more source
The impact of body composition variability on coagulation monitoring in patients on direct oral factor Xa inhibitors for treatment of venous thromboembolism. [PDF]
Kurzmann-Guetl K +9 more
europepmc +1 more source
Postoperative anastomotic embolism and elusive chronic nausea following pulmonary artery tear during single-port thoracoscopic lobectomy: a case report and examination of potential mechanisms. [PDF]
Chengkun D +7 more
europepmc +1 more source
Safety and efficacy of rivaroxaban versus warfarin in atrial fibrillation with stage 4 to 5 chronic kidney disease including dialysis. [PDF]
Almajdi A, Almutairi S, Alharbi M.
europepmc +1 more source
Pulmonary Vein Ostial Thrombosis after Atrial Fibrillation Ablation Leading to Stroke: Clinical Insights from a Rare Case. [PDF]
Tolunay H +4 more
europepmc +1 more source
An original less-invasive surgical treatment for arterial thoracic outlet syndrome caused by cervical rib. [PDF]
Alhames S +3 more
europepmc +1 more source
Direct Oral Anticoagulants Versus Warfarin in Atrial Fibrillation With Advanced Chronic Kidney Disease: A Systematic Review and Meta-Analysis. [PDF]
Metwaly AS +13 more
europepmc +1 more source
Trend of Reported Bleeding in Warfarin Compared with Direct Oral Anticoagulants in Japan. [PDF]
Takami A +4 more
europepmc +1 more source
Rivaroxaban treatment discontinuation rates in patients with nonvalvular atrial fibrillation in Italian clinical practice: RITMUS-AF. [PDF]
Pizzi C +18 more
europepmc +1 more source

